Short Interest in Keros Therapeutics, Inc. (NASDAQ:KROS) Declines By 13.7%
Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) was the recipient of a significant decline in short interest in the month of September. As of September 30th, there was short interest totalling 3,020,000 shares, a decline of 13.7% from the September 15th total of 3,500,000 shares. Based on an average trading volume of 346,000 shares, […]
16 Oct 10:16 · The Markets Daily